009290 — Kwangdong Pharmaceutical Co Share Price
- KR₩261bn
- KR₩356bn
- KR₩2tn
- 56
- 90
- 54
- 79
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.46 | ||
Price to Tang. Book | 0.49 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.16 | ||
EV to EBITDA | 6.44 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 6.54% | ||
Return on Equity | 7.55% | ||
Operating Margin | 2.67% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 1,238,254.7 | 1,243,769.6 | 1,338,181.55 | 1,431,545.26 | 1,514,454.15 | n/a | n/a | 5.11% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +15.38 | +72.99 | -49.19 | +0.04 | +71.82 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Kwangdong Pharmaceutical Co Ltd is a Korea-based company principally engaged in the manufacturing and distribution of pharmaceuticals. The Company operates its business through five segments. The Mineral Water Business segment supplies drinking spring water under Samdasoo brand. The Distribution Business segment distributes health drinks under brand names of Vita500 and Corn Silk Tea. The Pharmacy Business segment provides Chinese prescription cold medicines, hypertension medicines, cerebral apoplexy medicines and health drinks. The Hospital Business segment offers anticancer agents, blood vessel adjuvants, vitamin D injections and others. The Other segment provides products which not covered by Pharmacy, Hospital and Distribution segments.
Directors
- Seong Won Choi PRE (43)
- Hyeon Sik Kim VPR (59)
- Gwa Gyun Mo VPR (48)
- Yeong Deok Gi VPR (58)
- Sang Eon Cho MDR (59)
- Yin Jae Lee MDR (51)
- Chun Sik Choi OTH (52)
- Bo Hyeong Lee OTH (48)
- Cheol Su Park OTH (51)
- Ju Hyeong Park OTH (54)
- Sang Yeong Park OTH (50)
- Do Hui Won OTH (70)
- Gyeong Muk Yim NID (67)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- October 16th, 1963
- Public Since
- November 17th, 1989
- No. of Shareholders
- 33,495
- No. of Employees
- 888
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Korea Exchange - KSE
- Shares in Issue
- 40,080,612
![Blurred out image of a map](https://www.stockopedia.com/assets/conversion/images/maps_placeholder.jpg)
- Address
- Gasan Bldg., SEOUL, 06650
- Web
- http://www.ekdp.com/
- Phone
- +82 260067777
- Auditors
- Hyundai Accounting Co.
Upcoming Events for 009290
Q3 2024 Kwangdong Pharmaceutical Co Ltd Earnings Release
Similar to 009290
Aprogen Biologics
Korea Exchange - KSE
Boryung
Korea Exchange - KSE
Bukwang Pharm Co
Korea Exchange - KSE
Chong Kun Dang Pharmaceutical
Korea Exchange - KSE
CKD Bio
Korea Exchange - KSE
FAQ
As of Today at 21:44 UTC, shares in Kwangdong Pharmaceutical Co are trading at KR₩6,460. This share price information is delayed by 15 minutes.
Shares in Kwangdong Pharmaceutical Co last closed at KR₩6,460 and the price had moved by -1.07% over the past 365 days. In terms of relative price strength the Kwangdong Pharmaceutical Co share price has underperformed the FTSE Developed Asia Pacific Index by -5.34% over the past year.
The overall consensus recommendation for Kwangdong Pharmaceutical Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Kwangdong Pharmaceutical Co dividend yield is 1.55% based on the trailing twelve month period.
Last year, Kwangdong Pharmaceutical Co paid a total dividend of KR₩100, and it currently has a trailing dividend yield of 1.55%. We do not have any data on when Kwangdong Pharmaceutical Co is to next pay dividends.
We do not have data on when Kwangdong Pharmaceutical Co is to next pay dividends. The historic dividend yield on Kwangdong Pharmaceutical Co shares is currently 1.55%.
To buy shares in Kwangdong Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩6,460, shares in Kwangdong Pharmaceutical Co had a market capitalisation of KR₩259bn.
Here are the trading details for Kwangdong Pharmaceutical Co:
- Country of listing: Korea, Republic of
- Exchange: KSC
- Ticker Symbol: 009290
Based on an overall assessment of its quality, value and momentum Kwangdong Pharmaceutical Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kwangdong Pharmaceutical Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -12.28%.
As of the last closing price of KR₩6,460, shares in Kwangdong Pharmaceutical Co were trading -8% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Kwangdong Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩6,460.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Kwangdong Pharmaceutical Co's management team is headed by:
- Seong Won Choi - PRE
- Hyeon Sik Kim - VPR
- Gwa Gyun Mo - VPR
- Yeong Deok Gi - VPR
- Sang Eon Cho - MDR
- Yin Jae Lee - MDR
- Chun Sik Choi - OTH
- Bo Hyeong Lee - OTH
- Cheol Su Park - OTH
- Ju Hyeong Park - OTH
- Sang Yeong Park - OTH
- Do Hui Won - OTH
- Gyeong Muk Yim - NID